The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AASTROM BIOSCIENCES INC | COM PAR$ | 00253U404 | 681 | 238,900 | SH | SOLE | 238,900 | 0 | 0 | ||
ACHILLION PHARMACEUTICALS | COM | 00448Q201 | 259 | 26,000 | SH | SOLE | 26,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 3,007 | 145,342 | SH | SOLE | 145,342 | 0 | 0 | ||
AFFIMED THERAPEUTICS BV | COM | N01045108 | 756 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
AMPIO PHARMACEUTICALS INC | COM | 03209T109 | 530 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ATRICURE INC | COM | 04963C209 | 8,816 | 598,883 | SH | SOLE | 598,883 | 0 | 0 | ||
AUSPEX PHARMACEUTICALS INC | COM | 05211J102 | 3,902 | 152,002 | SH | SOLE | 152,002 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 747 | 76,400 | SH | SOLE | 76,400 | 0 | 0 | ||
BIOLIFE SOLUTIONS INC | COM NEW | 09062W204 | 244 | 116,279 | SH | SOLE | 116,279 | 0 | 0 | ||
BIOSPECIFICS TECHNOLOGIES | COM | 090931106 | 2,120 | 60,054 | SH | SOLE | 60,054 | 0 | 0 | ||
BIOTELEMETRY INC | COM | 090672106 | 1,581 | 235,645 | SH | SOLE | 235,645 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 897 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
CARDICA INC | COM | 14141R101 | 1,590 | 1,486,004 | SH | SOLE | 1,486,004 | 0 | 0 | ||
CAREDX INC | COM | 14167L103 | 525 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
CELSUS THERAPEUTICS PLC | SPONSORED ADR NE | 15119A202 | 268 | 43,900 | SH | SOLE | 43,900 | 0 | 0 | ||
CHEMBIO DIAGNOSTICS INC | COM NEW | 163572209 | 205 | 55,202 | SH | SOLE | 55,202 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 1,674 | 36,900 | SH | SOLE | 36,900 | 0 | 0 | ||
CURIS INC | COM | 231269101 | 212 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
CUTERA INC | COM | 232109108 | 896 | 88,694 | SH | SOLE | 88,694 | 0 | 0 | ||
CYNAPSUS THERAPEUTICS INC COM ACCD INVS | COM | 23257Y156 | 149 | 280,769 | SH | SOLE | 280,769 | 0 | 0 | ||
CYTRX CORP | COM PAR $.001 | 232828509 | 572 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
DERMA SCIENCES INC | COM PAR $.01 | 249827502 | 3,205 | 384,794 | SH | SOLE | 384,794 | 0 | 0 | ||
DISCOVERY LABORATORIES INC | COM NEW | 254668403 | 10,486 | 5,698,739 | SH | SOLE | 5,698,739 | 0 | 0 | ||
ENCISION INC | COM | 29254Q104 | 983 | 1,062,500 | SH | SOLE | 1,062,500 | 0 | 0 | ||
EXACTECH INC | COM | 30064E109 | 724 | 31,636 | SH | SOLE | 31,636 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 387 | 75,930 | SH | SOLE | 75,930 | 0 | 0 | ||
GALMED PHARMACEUTICALS LTD | SHS | M47238106 | 1,006 | 116,987 | SH | SOLE | 116,987 | 0 | 0 | ||
GENVEC INC | COM NEW | 37246C307 | 208 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
GLOBEIMMUNE INC | COM | 37957B100 | 74 | 10,745 | SH | SOLE | 10,745 | 0 | 0 | ||
INSPIREMD INC | COM NEW | 45779A309 | 140 | 63,700 | SH | SOLE | 63,700 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 4,032 | 109,418 | SH | SOLE | 109,418 | 0 | 0 | ||
INSULET CORP | NOTE 2.000% 6/1 | 45784PAD3 | 2,675 | 2,407,000 | PRN | SOLE | 2,407,000 | 0 | 0 | ||
INTELLIPHARMACEUTICS INTERNA | COM | 458173101 | 219 | 72,787 | SH | SOLE | 72,787 | 0 | 0 | ||
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 473 | 2,000 | SH | SOLE | 2,000 | 0 | 0 | ||
JOHNSON AND JOHNSON | COM | 478160104 | 1,002 | 9,400 | SH | SOLE | 9,400 | 0 | 0 | ||
LPATH INC | COM NEW | 548910306 | 362 | 102,798 | SH | SOLE | 102,798 | 0 | 0 | ||
LUMENIS LTD | SHS CL B | M6778Q121 | 259 | 29,018 | SH | SOLE | 29,018 | 0 | 0 | ||
MASIMO CORPORATION | COM | 574795100 | 372 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 1,036 | 66,141 | SH | SOLE | 66,141 | 0 | 0 | ||
NOVADAQ TECHNOLOGIES INC | COM | 66987G102 | 3,344 | 263,541 | SH | SOLE | 263,541 | 0 | 0 | ||
NUVASIVE INC | NOTE 2.750% 7/0 | 670704AC9 | 1,146 | 1,000,000 | PRN | SOLE | 1,000,000 | 0 | 0 | ||
NXSTAGE MEDICAL INC | COM | 67072V103 | 5,044 | 384,154 | SH | SOLE | 384,154 | 0 | 0 | ||
OCERA THERAPEUTICS INC | COM | 67552A108 | 3,311 | 675,650 | SH | SOLE | 675,650 | 0 | 0 | ||
ONCOTHYREON INC | COM | 682324108 | 413 | 214,972 | SH | SOLE | 214,972 | 0 | 0 | ||
PHARMACYCLICS INC | COM | 716933106 | 13,026 | 110,928 | SH | SOLE | 110,928 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | COM | 74365A101 | 3,118 | 1,288,440 | SH | SOLE | 1,288,440 | 0 | 0 | ||
RETRACTABLE TECHNOLOGIES INC | COM | 76129W105 | 58 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
RTI SURGICAL INC | COM | 74975N105 | 411 | 85,918 | SH | SOLE | 85,918 | 0 | 0 | ||
SCYNEXIS INC | COM | 811292101 | 370 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SPECTRANETICS CORP | COM | 84760C107 | 1,120 | 42,162 | SH | SOLE | 42,162 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 3,190 | 1,374,975 | SH | SOLE | 1,374,975 | 0 | 0 | ||
SYNERON MEDICAL LTD | ORD SHS | M87245102 | 911 | 90,947 | SH | SOLE | 90,947 | 0 | 0 | ||
TARGACEPT INC | COM | 87611R306 | 339 | 133,972 | SH | SOLE | 133,972 | 0 | 0 | ||
THRESHOLD PHARMACEUTICALS | COM NEW | 885807206 | 2,007 | 555,965 | SH | SOLE | 555,965 | 0 | 0 | ||
TONIX PHARMACEUTICALS HLDG C | COM NEW | 890260201 | 171 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
UNIQURE | SHS | N90064101 | 296 | 32,000 | SH | SOLE | 32,000 | 0 | 0 | ||
UROPLASTY INC | COM NEW | 917277204 | 1,215 | 486,062 | SH | SOLE | 486,062 | 0 | 0 | ||
VENAXIS INC | COM | 92262A107 | 1,092 | 658,000 | SH | SOLE | 658,000 | 0 | 0 | ||
XENOPORT INC | COM | 98411C100 | 1,292 | 240,190 | SH | SOLE | 240,190 | 0 | 0 |